Intratympanic corticosteroid injection for Ménière’s disease: systematic review of randomized controlled trials
This review highlights the persistent uncertainty surrounding the clinical effectiveness of ITCs in MD. While some evidence supports modest benefit for vertigo control, inconsistencies and low certainty limit generalizability. Future RCTs should prioritize standardized outcome measures and robust methodological design to better define the therapeutic role of ITCs in Menière´s disease.MD.
Authors
- Manuel Bernal‐Sprekelsen (ORCID: https://orcid.org/0000-0001-8191-9833)
- Marta Sandoval (ORCID: https://orcid.org/0000-0001-6813-6623)
- Joan Remacha (ORCID: https://orcid.org/0000-0002-3850-9422)
- Humberto Quiroz Martínez
- Francesc Larrosa
Institutions
- Hospital Clínic de Barcelona (ES)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- European Archives of Oto-Rhino-Laryngology
- Published
- 2025-11-15
- DOI
- https://doi.org/10.1007/s00405-025-09764-4
- Primary Topic
- Vestibular and auditory disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00